Abstract:Objective: To develop and validate a risk scoring tool to identify those who are at increased risk of chlamydia infection. Methods: We used demographic data, sexual behaviour information and chlamydia positivity results from more than 45 000 individuals who attended Sydney Sexual Health Centre between 1998 and 2009. Participants were randomly allocated to either the development or internal validation data set. Using logistic regression, we created a prediction model and weighted scoring system using the development data set and calculated the odds ratio of chlamydia positivity for participants in successively higher quintiles of score. The internal validation data set was used to evaluate the performance characteristics of the model for five quintiles of risk scores including population attributable risk, sensitivity and specificity. Results: In the prediction model, inconsistent condom use, increased number of sexual partners in last 3 months, genital or anal symptoms and presenting to the clinic for sexually transmitted infections screening or being a contact of a sexually transmitted infection case were consistently associated with increased risk of chlamydia positivity in all groups. High scores (upper quintiles) were significantly associated with increased risk of chlamydia infection. A cut-point score of 20 or higher distinguished a increased risk group with a sensitivity of 95%, 67% and 79% among heterosexual men, women and men who have sex with men (MSM), respectively. Conclusion: The scoring tool may be included as part of a health promotion and/or clinic website to prompt those who are at increased risk of chlamydia infection, which may potentially lead to increased uptake and frequency of testing. INTRODUCTION Chlamydia infection is highly prevalent in young heterosexuals and men who have sex with men (MSM) in Australia, with prevalence estimates of 3e5% in both populations. 2 The majority of chlamydia infections are asymptomatic. Chlamydia is associated with sequelae such as pelvic inflammatory disease and infertility in women and proctitis in men. Also in MSM, chlamydia re-infection of the rectum has been associated with an increased risk of HIV seroconversion. The number of chlamydia notifications continues to increase steadily each year among MSM and young heterosexual men and young women in Australia, 9 as in many other countries. A major public health challenge is therefore to identify individuals at risk of chlamydia and facilitate testing and treatment before the development of chlamydia sequelae and onward transmission to To cite: Wand H, Guy R, Donovan B, et al. Developing and validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia: a simple algorithm to identify those at high risk of chlamydia infection. BMJ Open 2011;1:e000005. doi:10.1136/bmjopen-2010000005 < Prepublication history for this paper is available online. To view these files please visit the journal online (http:// bmjopen.bmj.com). Received 26 September 2010 Accepted 6 January 2011 This final article is available for use under the terms of the Creative Commons Attribution Non-Commercial 2.0 Licence; see http://bmjopen.bmj.com National Centre in HIV Epidemiology and Clinical Research, Sydney, New South Wales, Australia Sydney Sexual Health Centre, Sydney, New South Wales, Australia National Centre in HIV Social Research, University of New South Wales, Sydney, New South Wales, Australia Correspondence to Dr Handan Wand; hwand@nchecr.unsw.edu.au ARTICLE SUMMARY Article focus The authors created a risk assessment tool that allows people to estimate their own chlamydia risk score based on simple non-invasive variables. Key messages The tool described here will potentially provide a simple and cost-effective method of identifying and alerting individuals who would benefit from chlamydia screening. This tool may be included as part of a health promotion and/or clinic website. This tool may potentially lead to increased uptake and frequency of testing. Strengths and Limitations This is the first study to utilize statistical methods to derive a locally-specific assessment tool using 12 years of data from more than 45 000 men and women. The Study population was sexual health clinic attendees who are likely to be at higher risk for Chlamydia infection compared to the general population. Wand H, Guy R, Donovan B, et al. BMJ Open 2011;1:e000005. doi:10.1136/bmjopen-2010-000005 1 Open Access Research group.bmj.com on June 12, 2017 Published by http://bmjopen.bmj.com/ Downloaded from

Intraoperative localisation of a urachal bladder tumour prior to partial cystectomy.

White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia

Nanoparticle Formulations for the Improvement of Symptomatic Treatments of Neurodegenerative Disorders

Alpha-2,6-difluorophenyl-N-tert-butylnitrone: a spin trap for distinguishing different types of alkyl radicals based on long-range fluorine hyperfine splitting.

chlamydia infection algorithm to identify those at high risk of clinic attendees in Australia : a simple for chlamydia infection among sexual health Developing and validating a risk scoring tool

Alzheimer's Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions

Exploring the Connection Between Nanomaterials and Neurodegenerative Disorders

Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases

Effect of acoustic tumor extension into the internal auditory canal on distortion-product otoacoustic emissions.

Nanotechnological advancement for the treatment of neurodegenerative disorders

Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications

Quaternary structure of pig liver phosphofructokinase.

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease

Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease

The chromosomes of fifty primary Rous rat sarcomas.

Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease

Recent advances in nanotechnology and its application for neuro-disease: a review

Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance

Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease